Difficult Access Requires Thought, Training and Technology (DART3): An implementation study investigating the effect of a co-developed escalation pathway on peripheral intravenous catheter insertion success and insertion-related complications in patients with difficult intravenous access.

Not Applicable

Recruiting

• Conditions: Difficult intravenous access; Public Health - Health service research

• Registration Number: ACTRN12621001497897
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-04
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1680

Inclusion Criteria

Cluster eligibility is emergency department, inpatient ward or day procedure unit where >10 PIVCs/week are typically inserted. Across each cluster at each participating hospital, any PIVC, inclusive of short and long PIVC being inserted may be considered for inclusion. Patient eligibility: Patient (DIVA or non-DIVA) of any age (neonate to elderly) prescribed PIVC insertion.

Exclusion Criteria

Exclusion criteria are: Emergencies (e.g. MET call) requiring intraosseous access. Exclusion areas are operating theatres, radiology, rehabilitation or psychiatric units because they either have all expert inserters so have less insertion failure, or rarely insert PIVCs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
First attempt success: one needle puncture, by one inserter; to achieve PIVC insertion for DIVA patients; collected using study-specific checklist and review of patients' medical records.[Timepoint 0: Baseline prior to introducing the intervention;<br>Timepoint 1: During the implementation of the intervention (months 3 to 10 after baseline; the dates on which data collection occurs in each cluster will be randomly selected during the intervention phase using computer generated allocation. Data will be collected from 10 PIVCs per cluster per month. Each PIVC will only be studied once at the following phases of PIVC care: on insertion, once per day, on removal, 48 hours after removal);<br>Timepoint 2: +3 month after the implementation of the intervention; and,<br>Timepoint 3: +6 months after the implementation of the intervention]